Noriko Aida1,2, Jun Shibasaki3, Moyoko Tomiyasu1,2, Yuri Nishi1,4, Naho Morisaki4, Takeo Fujiwara4, Katsuaki Toyoshima3, and Takayuki Obata2
1Radiology, Kanagawa Children's Medical Center, Yokohama, Japan, 2Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan, 3Neonatology, Kanagawa Children's Medical Center, Yokohama, Japan, 4Social Medicine, National Research Institute for Child Health and Development, Tokyo, Japan
Synopsis
Absolute
metabolite concentrations of N-acethylaspartate (NAA), Choline(Cho) and Creatine(Cr)
in the deep gray matter of 44 near term neonates with hypoxic-ischemic
encephalopathy (HIE), measured using PRESS method short echo 1H-MRS within
2 weeks after birth, showed excellent prognostic values (AUC; NAA: 0.98, Cho: 0.96,
Cr: 0.99) with the adverse outcomes having significantly lower measurements
compared to those with favorable outcomes, while Lactate was less efficient
(AUC 0.74). Moreover NAA and Cr concentrations measured at 24-96 hours revealed
perfect prognostic values (AUC 1.00). Early
measurement of absolute Cr and NAA concentrations can be excellent biomarkers
of infants suffered with neonatal HIE.Background
and Purpose
Early and accurate assessment of brain damage in neonatal
hypoxic-ischemic encephalopathy (HIE) can be useful to predict its long term
consequences. A meta-analysis concluded that deep gray matter Lactate (Lac)/
N-acethylaspartate (NAA) and Lac/Creatine (Cr) have superior prognostic
accuracy than conventional or diffusion-weighted MRI
1. However,
ratios can change by alteration of either of the metabolites involved, thus
limiting understanding of how metabolism disturbances are associated with
neuro-impairment. Our purpose was to investigate the prognostic ability of
absolute metabolite concentrations (NAA, Cr, Choline(Cho) and Lac) of the deep
gray matter in neonates with HIE.
Methods
Patients
and clinical data: 44 of 48 near term neonates (at least
35 gestational weeks) with HIE (Sarnat grade II or III) treated in a single
NICU unit in Japan from October 2009 to January 2014 were included (4 infants were
excluded: 1 with congenital heart disease, 3 lost to follow-up). All underwent
MR examinations within 2 weeks of birth: 16 had early exams at 24-96 hours, 41
had late exams at 7-14 days, and 13 had exams at both time points.
Neurodevelopmental outcome was assessed at 18–24 months corrected age by
determining the developmental quotient (DQ) using the Kyoto Scale of
Psychological Development (KSPD), and functional disability according to the
Gross Motor Function Classification System (GMFCS). Neurodevelopmental
impairment (NDI) was defined as a GMFCS grade of level 2–5 or a DQ <70,
adverse outcome as death or survival with NDI, and favorable outcome as
survival without NDI.
MR
Spectroscopy: 1H-MRS were acquired in the deep gray
matter [Fig.1] on 3T clinical scanners (MAGNETIM Verio, Siemens) using 12 or 32
channel head coils. The acquisition parameters were as follows: PRESS sequence
with water suppression pulse; TE/TR: 30/5000 ms; number of excitations: 4 to 16; spectral bandwidth: 2000Hz;
number of points: 1024. For the signal quantification,
reference scans without water suppression were also acquired. The total acquisition
time was about 5 min. The data processing was performed using LCModel [Fig.1].
Metabolite concentrations were automatically calculated by comparing the proton
peaks of the metabolites without water suppression in the same voxel. The
reference water concentration was assumed to be 48.9M 2.
Statistics:
Fisher’s exact test and Mann-Whitney-Wilcoxon test was used to compare
background characteristics and absolute metabolite concentrations of infants
with adverse and favorable outcomes. For each metabolite, receiver operator
characteristics (ROC) curves were calculated using logistic regression, from
which area under curve (AUC), and cut-off with optimum sensitivity and
positivity were determined.
Results
8 had adverse and 36 had favorable outcomes. Gestational age, birth
weight, male/female ratio, Apgar score at 5 and 10 minutes, pH of the umbilical
blood, proportion of infants given hypothermia treatment, and age (in days) MR
was taken, did not differ significantly between the two groups [
Table 1]. Measurement’s
median and prognostic utilities of quantitated absolute metabolites concentrations
by outcome are shown in
Tables 2 and 3. NAA, Cho and Cr concentrations showed
excellent prognostic values (AUC 0.96 to 0.99) with the adverse outcomes having
significantly lower measurements compared to those with favorable outcomes in
all measurement timing, while Lac was less efficient (AUC 0.74). NAA and Cr
concentrations measured at early examinations revealed perfect prognostic
values (AUC 1.00).
Figure 2 shows distributions of absolute concentration of 4
metabolites by age at measurement. All measurements of infants with adverse
outcome revealed lower NAA, Cho and Cr concentrations than the cutoff values,
regardless of measurement timing.
Discussion
It is understandable that low absolute NAA concentration predict adverse
outcomes. However, it is surprising that those of Cho and Cr revealed such high
AUC values. Moreover absolute concentration of Cr had a little higher AUC than
that of NAA. We speculate brain energy level and cell membranous proliferation of infants
with adverse outcome would become lower shortly after the injury from HIE. It
means some MRS evaluations by the ratio to assume such metabolites a denominator
would have a problem. Absolute concentrations were well quantified by short
echo PRESS sequence with higher signal noise ratios except for Lac which was
overlapped with the peaks of lipid/macromolecules in short echo
1H-MRS. However, visual
detection of elevated lactate with typical twin peaks was easy and we could use it clinically as a biomarker for poor outcome.
Conclusion
Absolute
low Cr and NAA concentration data quantified by 1H-MRS with short echo
sequence within 2 weeks after birth clearly predict adverse long-term prognosis
and particularly outstanding in the measurements at 24-96 hours. Absolute Cr
and NAA concentration within 2 weeks can be excellent biomarkers of infants
suffered with neonatal HIE.
Acknowledgements
This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI
Grant Number 26461843.References
1. Thayyil S, et al. Cerebral magnetic
resonance biomarkers for predicting neurodevelopmental outcome following
neonatal encephalopathy: a meta-analysis. Pediatrics. 2010;125(2): e382-95.
2. Williams LA, et al. Neonatal brain:
Regional variability of in Vivo MR imaging relaxation rates at 3.0 T –Initial
experience. Radiology 2005; 235:595-603